DSpace at RU >

Browsing by Author Jansen, T.L.Th.A.

Full Text	Issue Date	Title	Author(s)
	2011	The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis	Brinkman, I.H.; Laar, M.A. van der; Jansen, T.L.Th.A.; Roon, E.N. van
	2011	Proton transport in a binary biomimetic solution revealed by molecular dynamics simulation	Liang, C.; Jansen, T.L.Th.A.
	2011	EULAR recommendations for calcium pyrophosphate deposition. Part II: management	Zhang, W.; Doherty, M.; Pascual, E.; Barskova, V.; Guerne, P.A., et al
	2011	Spiegelinformatie omtrent gebruik van TNFα-remmers in de Nederlandse reumatologie (mei 2011).	Jansen, T.L.Th.A.; Albada-Kuipers, G.A. van; Dijkmans, B.A.C.
	2011	Proton transport in biological systems can be probed by two-dimensional infrared spectroscopy	Liang, C.; Jansen, T.L.Th.A.; Knoester, J.
	2011	De CQ-index Reumatische Aandoeningen: hanteerbaar en geschikt voor visitatie?	Oosterhuis, T.; Delnoij, D.M.; Kortenhoeven, P.J.; Sibma, T.S.; Geurts, M.A.W., et al
	2011	Effectiveness of a Third Tumor Necrosis Factor-alpha-blocking Agent Compared with Rituximab After Failure of 2 TNF-blocking Agents in Rheumatoid Arthritis	Blom, M.; Kievit, W.; Donders, A.R.T.; Broeder, A. den; Straten, V.H., et al
	2011	Analysis of 2D CS spectra for systems with non-gaussian dynamics	Roy, S.; Pshenichnikov, M.S.; Jansen, T.L.Th.A.
	2011	[The multidisciplinary practice guideline 'The responsible use of biologicals'].	Bijlsma, J.W.J.; Hagemeijer, J.W.; Bijl, M. van der; Jansen, T.L.Th.A.; Laar, M.A. van der, et al
	2011	On the nature of OH-stretching vibrations in hydrogen-bonded chains: pump frequency dependent vibrational lifetime	Knop, S.; Jansen, T.L.Th.A.; Lindner, J.; Vohringer, P.
	2011	Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis	Arends, S.; Veer, E. van der; Groen, H.; Houtman, P.M.; Jansen, T.L.Th.A., et al
	2011	Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry	Arts, E.E.A.; Jansen, T.L.Th.A.; Broeder, A. den; Vonkeman, H.E.; Dutmer, E., et al
	2011	European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis	Zhang, W.; Doherty, M.; Bardin, T.; Barskova, V.; Guerne, P.A., et al
	2011	Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.	Arends, S.; Brouwer, E.; Veer, E. van der; Groen, H.; Leijsma, M.K., et al
	2011	Commitment voor de doelmatigheidsstudie PO-EET.	Jansen, T.L.Th.A.; Albada-Kuipers, G.A. van; Dijkmans, B.A.C.
	2011	From atomistic modeling to excitation transfer and two-dimensional spectra of the FMO light-harvesting complex	Olbrich, C.; Jansen, T.L.Th.A.; Liebers, J.; Aghtar, M.; Strumpfer, J., et al
	2011	A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor alpha inhibitor	Kwakernaak, A.J.; Houtman, P.M.; Weel, J.F.; Spoorenberg, J.P.; Jansen, T.L.Th.A.
	2011	Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature	Wink, F.; Houtman, P.M.; Jansen, T.L.Th.A.
	2010	Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome	Coenen, M.J.H.; Enevold, C.; Barrera, P.; Schijvenaars, M.M.V.A.P.; Toonen, E.J.M., et al
	2010	Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice.	Blom, M.; Kievit, W.; Kuper, H.H.; Jansen, T.L.Th.A.; Visser, H., et al
	2010	Structural classification of the amide I sites of a beta-hairpin with isotope label 2DIR spectroscopy.	Roy, S.; Jansen, T.L.Th.A.; Knoester, J.
	2010	Melting of a beta-hairpin peptide using isotope-edited 2D IR spectroscopy and simulations.	Smith, A.W.; Lessing, J.; Ganim, Z.; Peng, C.S.; Tokmakoff, A., et al
	2010	New advances in the treatment of gout: review of pegloticase	Reinders, M.K.; Jansen, T.L.Th.A.
	2009	The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis.	Blom, M.; Kievit, W.; Fransen, J.; Kuper, I.H.; Broeder, A. den, et al
	2009	Richtlijn ‘Diagnostiek en behandeling van reumatoïde artritis’	Schipper, L.G.; Hoekstra, M.O.; Vliet Vlieland, T.P.M.; Jansen, T.L.Th.A.; Lems, W.F., et al
	2009	Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.	Radovits, B.J.; Kievit, W.; Fransen, J.; Laar, M.A. van de; Jansen, T.L.Th.A., et al
	2009	Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies.	Kievit, W.; Fransen, J.; Adang, E.M.M.; Kuper, H.H.; Jansen, T.L.Th.A., et al
	2008	The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data.	Kievit, W.; Adang, E.M.M.; Fransen, J.; Kuper, H.H.; Laar, M.A.F.J. van de, et al
	2007	The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.	Kievit, W.; Fransen, J.; Oerlemans, A.J.M.; Kuper, H.H.; Laar, M.A.F.J. van de, et al
	2007	Professionele kwaliteit : vanzelfsprekendheid of nieuwerwetse koopwaar?	Jansen, T.L.Th.A.; Geurts, M.A.W.; Riel, P.L.C.M. van
	1997	Severe hypercalcaemia syndrome with daily low-dose vitamin D supplementation	Jansen, T.L.Th.A.; Janssen, M.; Jong, A.J.L. de
	1997	Epidemiology of celiac disease in The Netherlands	George, E.K.; Jansen, T.L.Th.A.; Mearin, M.L.; Mulder, C.J.J.
	1997	Hypercalciemiesyndroom uitgelokt door dagelijks gebruik van 400 IE cholecalciferol bij een 85-jarige dame met prednison-osteoporose	Traksel, M.; Jansen, T.L.Th.A.; Janssen, M.; Jong, A.J.L. de
	1996	Effect of atrial natriuretic factor on skin microcirculation versus skeletal muscle blood flow	Branten, A.J.W.; Smits, P.; Jansen, T.L.Th.A.; Wollersheim, H.C.H.; Thien, Th.
	1996	Hypophosphatemic osteomalacia in an elderly patient with generalized bone pain	Jansen, T.L.Th.A.; Vries, R.A. de; Verschoor, L.
	1996	Stikstofmonoxide van belang voor de reumatologie?	Jansen, T.L.Th.A.